8-K
Current Report
Chemomab Therapeutics Ltd. Filed Acc 0001104659-20-064770
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading tm2020375d1_8k.htm…